On Tuesday, the Senate officially confirmed Terrance Cole as the new Administrator of the Drug Enforcement Administration (DEA), marking the first permanent leadership appointment to the agency under President …
The United States Sentencing Commission (USSC) had an opportunity during this most recent amendment cycle to make significant and meaningful changes to the Sentencing Guidelines that would at least begin …
The History of SB 1012 Following Measure 109‘s success in November 2020 in Oregon, California Senator Scott Wiener introduced SB519 in January 2021. California Governor Gavin Newsom eventually vetoed …
Richard Nixon announced the War on Drugs in 1971 and, in doing so, perpetuated an ongoing rhetoric and myth of Black criminality. Ronald Reagan escalated the impact of this policy by prioritizing punishment …
Evidence demonstrates, and the general public believes, cannabis should be legal for adult use. President Biden has repeatedly promised to decriminalize cannabis, but even before the President’s proclamation, …
The first half of 2024 has been riveting for a few reasons. By now, Oregon’s regulated access program has been in effect for eighteen months, with thousands of people having received psilocybin services; …
Distinctions in Australian MDMA and Psilocybin Policy The Therapeutic Goods Administration (TGA) in Australia recently announced a new policy allowing for the limited use of psychedelic-assisted therapies …
FOR IMMEDIATE RELEASE: February 3, 2023 The Therapeutic Goods Administration (TGA) in Australia announced today that they will permit limited use of certain psychedelic-assisted therapies for the treatment …
“Australia’s policy change is one that every country should consider: suffering people, regardless of nationality, need more opportunities to access novel treatments,” MAPS founder and director Dr. …
After decades of criminalization, Australia’s government said Friday that it will legalize the prescription of MDMA and psilocybin for the treatment of two medical conditions, a historic move hailed …
In early January, MAPS announced that MAPP2 met pre-specified primary and key secondary endpoints and that it planned to file a new drug application submission in the third quarter of 2023. At the end …
November 17, 2022 MAPS celebrates the formation of the Congressional Psychedelics Advancing Clinical Treatments (PACT) Caucus, announced today. Led by Representatives Lou Correa (D-CA) and Jack Bergman …
